MRI vs. CT for pancreatic adenocarcinoma vascular invasion: comparative diagnostic test accuracy systematic review and meta-analysis.
Ankush JajodiaAshley WangMostafa AlabousiChristopher WilksAmeya KulkarniChristian B van der PolPublished in: European radiology (2023)
• Based on limited data, no difference was found between MRI and pancreatic protocol CT sensitivity and specificity for diagnosing PDAC vascular invasion (p = 0.81, 0.73 respectively). • Risk of bias could be reduced in future PDAC MRI vs CT comparative diagnostic test accuracy research by ensuring all enrolled patients undergo both imaging modalities being compared in random order and regardless of the findings on either modality. • More studies are needed that directly compare the diagnostic performance of MRI and CT for PDAC staging after neoadjuvant therapy.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- dual energy
- diffusion weighted imaging
- image quality
- end stage renal disease
- lymph node
- chronic kidney disease
- newly diagnosed
- high resolution
- randomized controlled trial
- cell migration
- rectal cancer
- positron emission tomography
- prognostic factors
- machine learning
- squamous cell carcinoma
- mesenchymal stem cells
- radiation therapy
- cell therapy
- mass spectrometry
- bone marrow